Evidence map›Paper›PMID 37972002›Full record

ArticlePloS one2023

How well does NamSor perform in predicting the country of origin and ethnicity of individuals based on their first and last names?

Paul Sebo

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Paul SeboUniversity Institute for Primary Care (IuMFE), University of Geneva, Geneva, Switzerland.ORCID 0000-0001-7616-0017

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to evaluate NamSor's performance in predicting the country of origin and ethnicity of individuals based on their first/last names.

methodsWe retrieved the name and country of affiliation of all authors of PubMed publications in 2021, affiliated with universities in the twenty-two countries whose researchers authored ≥1,000 medical publications and whose percentage of migrants was <2.5% (N = 88,699). We estimated with NamSor their most likely "continent of origin" (Asia/Africa/Europe), "country of origin" and "ethnicity". We also examined two other variables that we created: "continent#2" ("Europe" replaced by "Europe/America/Oceania") and "country#2" ("Spain" replaced by "Spain/Hispanic American country" and "Portugal" replaced by "Portugal/Brazil"). Using "country of affiliation" as a proxy for "country of origin", we calculated for these five variables the proportion of misclassifications (= errorCodedWithoutNA) and the proportion of non-classifications (= naCoded). We repeated the analyses with a subsample consisting of all results with inference accuracy ≥50%.

resultsFor the full sample and the subsample, errorCodedWithoutNA was 16.0% and 12.6% for "continent", 6.3% and 3.3% for "continent#2", 27.3% and 19.5% for "country", 19.7% and 11.4% for "country#2", and 20.2% and 14.8% for "ethnicity"; naCoded was zero and 18.0% for all variables, except for "ethnicity" (zero and 10.7%).

conclusionNamSor is accurate in determining the continent of origin, especially when using the modified variable (continent#2) and/or restricting the analysis to names with accuracy ≥50%. The risk of misclassification is higher with country of origin or ethnicity, but decreases, as with continent of origin, when using the modified variable (country#2) and/or the subsample.

Indexed as

EthnicityAfricaAsiaEuropeHumansSpain

Identifiers

PMID37972002
PMCPMC10653483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.